RESÚMENES NOVIEMBRE 2005

.

Other Neuropsychiatric Disorders & General Information

(Haga un click en la información del journal para acceder al resúmen)

 

A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of "vascular depression"
Taragano FE, Bagnatti P, Allegri RF

Int Psychogeriatr. 2005 Sep;17(3):487-98

 

Clustering of suicides among people with mental illness

NIGEL McKENZIE, SABINE LANDAU, NAVNEET KAPUR, JANET MEEHAN, JO ROBINSON, HARRIET BICKLEY, REBECCA PARSONS, LOUIS APPLEBY

The British Journal of Psychiatry (2005) 187: 476-480

Potentially hazardous drug interactions with psychotropics

Ben Chadwick, Derek G. Waller and J. Guy Edwards

Advances in Psychiatric Treatment (2005) 11: 440-449

Epidemiology of and Risk Factors for Psychosis of Alzheimer’s Disease: A Review of 55 Studies Published From 1990 to 2003

Susan A. Ropacki, Dilip V. Jeste

Am J Psychiatry 162:2022-2030, November 2005

Pharmacological Modulation of Prefrontal Cortical Activity During a Working Memory Task in Young and Older Humans: A PET Study With Physostigmine

Ulderico Freo, Emiliano Ricciardi, Pietro Pietrini, Mark B. Schapiro, Stanley I. Rapoport, Maura L. Furey

Am J Psychiatry 162:2061-2070, November 2005

The Construct of Minor and Major Depression in Alzheimer’s Disease

Sergio E. Starkstein, Ricardo Jorge, Romina Mizrahi, Robert G. Robinson

Am J Psychiatry 162:2086-2093, November 2005

Depressive Symptoms and 24-Hour Urinary Norepinephrine Excretion Levels in Patients With Coronary Disease: Findings From the Heart and Soul Study

Christian Otte, Thomas C. Neylan, Sharon S. Pipkin, Warren S. Browner, Mary A. Whooley

Am J Psychiatry 162:2139-2145, November 2005

Association of Resolution of Major Depression With Increased Natural Killer Cell Activity Among HIV-Seropositive Women

Dean G. Cruess, Steven D. Douglas, John M. Petitto, Thomas Ten Have, David Gettes, Benoit Dubé, Mark Cary, Dwight L. Evans

Am J Psychiatry 162:2125-2130, November 2005

Suicide Attempters’ Reaction to Survival as a Risk Factor for Eventual Suicide

Gregg Henriques, Amy Wenzel, Gregory K. Brown, Aaron T. Beck

Am J Psychiatry 162:2180-2182, November 2005

Impulse Control Disorders in Adult Psychiatric Inpatients

Jon E. Grant, Laura Levine, Daniel Kim, Marc N. Potenza

Am J Psychiatry 162:2184-2188, November 2005

 

Reduced Anterior and Posterior Cingulate Gray Matter in Borderline Personality Disorder
Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ, Chen AD, Mitropoulou V, Minzenberg M, Siever LJ, Buchsbaum MS

Biol Psychiatry. 2005 Jul 1; [Epub ahead of print]

 

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain
Raskin J, Pritchett YL, Wang F, D'Souza DN, Waninger AL, Iyengar S, Wernicke JF

Pain Med. 2005 Sep-Oct;6(5):346-56

 

Comparison of the effects of two antidepressants on exercise performance of the female patients with fibromyalgia
Ozerbil O, Okudan N, Gokbel H, Levendoglu F

Clin Rheumatol. 2005 Nov 3;:1-3 [Epub ahead of print]

 

Neuropsychiatric symptoms in patients with multiple sclerosis
Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, Harboe E, Omdal R, Aarsland D

Acta Psychiatr Scand 2005: 1–6

 

Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors
Golden J, O'dwyer AM, Conroy RM

Gen Hosp Psychiatry. 2005 Nov-Dec;27(6):431-8

 

The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans

Sue J. Wilson, Jayne E. Bailey, Ann S. Rich, Jon Nash, Mariona Adrover, A. Tournoux, David J. Nutt

Journal of Psychopharmacology, Vol. 19, No. 6, 609-613 (2005)

Gender differences in response to lorazepam in a human drug discrimination study

Anne Jackson, David Stephens, Theodora Duka

Journal of Psychopharmacology, Vol. 19, No. 6, 614-619 (2005)

The efficacy and safety of quetiapine for treatment of geriatric psychosis

Cheng-Hung Yang, Shih-Jen Tsai, Jen-Ping Hwang

Journal of Psychopharmacology, Vol. 19, No. 6, 661-666 (2005)

Frontal Lobe Hypometabolism and Impaired Insight in Alzheimer Disease

Dylan G. Harwood, David L. Sultzer, Denise Feil, Lorena Monserratt, Evan Freedman, Mark A. Mandelkern

Am J Geriatr Psychiatry 13:934-941, November 2005

Divalproex Sodium in Nursing Home Residents With Possible or Probable Alzheimer Disease Complicated by Agitation. A Randomized, Controlled Trial

Pierre N. Tariot, Rema Raman, Laura Jakimovich, Lon Schneider, Anton Porsteinsson, Ronald Thomas, Jacobo Mintzer, Ronald Brenner, Kim Schafer, Leon Thal, for the Alzheimer’s Disease Cooperative Study/Valproate Nursing Home Study Group

Am J Geriatr Psychiatry 13:942-949, November 2005

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone. A Preliminary Study

G. Stennis Watson, Brenna A. Cholerton, Mark A. Reger, Laura D. Baker, Stephen R. Plymate, Sanjay Asthana, Mark A. Fishel, J. Jacob Kulstad, Pattie S. Green, David G. Cook, Steven E. Kahn, Michelle L. Keeling, Suzanne Craft

Am J Geriatr Psychiatry 13:950-958, November 2005

Racial Differences in the Progression of Cognitive Decline in Alzheimer Disease

Lisa L. Barnes, Robert S. Wilson, Yan Li, Neelum T. Aggarwal, David W. Gilley, Judith J. McCann, Denis A. Evans

Am J Geriatr Psychiatry 13:959-967, November 2005

Racial Differences in Cognitive Decline in a Sample of Community-Dwelling Older Adults. The Mediating Role of Education and Literacy

Natalie Sachs-Ericsson, Dan G. Blazer

Am J Geriatr Psychiatry 13:968-975, November 2005

Hallucinations and Mortality in Alzheimer Disease

Robert S. Wilson, Kristin R. Krueger, Julia M. Kamenetsky, Yuxiao Tang, David W. Gilley, David A. Bennett, Denis A. Evans

Am J Geriatr Psychiatry 13:984-990, November 2005

Cortical Activation During Cholinesterase-Inhibitor Treatment in Alzheimer Disease. Preliminary Findings From a Pharmaco-fMRI Study

Tilo T.J. Kircher, Michael Erb, Wolfgang Grodd, Dirk T. Leube

Am J Geriatr Psychiatry 13:1006-1013, November 2005

Binge eating disorder in obesity: comparison of different therapeutic strategies
Molinari E, Baruffi M, Croci M, Marchi S, Petroni ML

Eat Weight Disord. 2005 Sep;10(3):154-61

 

Neuropsychiatric Aspects of Migraine
B Lee Peterlin and Thomas N Ward
Current Psychiatry Reports 2005, 7:371-375

 

Vitamin E Supplementation in Alzheimer's Disease, Parkinson's Disease, Tardive Dyskinesia, and Cataract: Part 2

David Q Pham, Roda Plakogiannis

The Annals of Pharmacother. Nov 15, 2005

 

Pregabalin: A New Neuromodulator with Broad Therapeutic Indications

Bassel F Shneker, James W McAuley

The Annals of Pharmacother. Nov 15, 2005

 

An Overview of Drug-Induced Liver Disease

Jiwon Kim

US Pharm. 2005;11:HS-10-HS-21

 

Drug-induced tremors

John C Morgan and Kapil D Sethi

The Lancet Neurology. Volume 4, Issue 12, December 2005, Pages 866-876

 

Dissecting the suicide phenotype: the role of impulsive–aggressive behaviours

Gustavo Turecki

J Psychiatry Neurosci 2005;30(6):398-408

 

Medication Utilization Patterns and Methods of Suicidality in Borderline Personality Disorder

Eugene H Makela, Karen E Moeller, Jennifer E Fullen, Erdogan Gunel

Annals Pharmacother Jan 2005

 

Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey

M. ELENA MEDINA-MORA, GUILHERME BORGES, CARMEN LARA, CORINA BENJET, JERÓNIMO BLANCO, CLARA FLEIZ, JORGE VILLATORO, ESTELA ROJAS and JOAQUÍN ZAMBRANO

Psychological Medicine (2005), 35: 1773-1783

 

Best practice guidelines for the management of women with epilepsy
Crawford P

Epilepsia. 2005 Nov;46 Suppl 9:117-24

How age influences the expression of narcolepsy

Maurice M. Ohayon, Luidgi Ferini-Strambi, Giuseppe Plazzi, Salvatore Smirne, Vincenza Castronovo

J Psychosom Res Volume 59, Issue 6, Pages 399-405

 

Diagnostic indicators of sleep apnea in older women and men: A prospective study

Sally Bailes, Marc Baltzan, Iris Alapin, Catherine S. Fichten, Eva Libman

J Psychosom Res Volume 59, Issue 6, Pages 365-373

 

 

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF

Pain. 2005 Nov 16; [Epub ahead of print] 

Fluoxetine Treatment in Poststroke Depression, Emotional Incontinence, and Anger Proneness. A Double-Blind, Placebo-Controlled Study
Choi-Kwon S, Han SW, Kwon SU, Kang DW, Choi JM, Kim JS

Stroke. 2005 Nov 23; [Epub ahead of print]

 

THE EXPERT CONSENSUS PANEL FOR BEHAVIORAL EMERGENCIES 2005 - Introduction: Methods, Commentary, and Summary
ALLEN, MICHAEL H; CURRIER, GLENN W; CARPENTER, DANIEL; ROSS, RUTH W; DOCHERTY, JOHN P

Journal of Psychiatric Practice. 11 Supplement 1:5-25, November 2005

Transsexual subtypes: Clinical and theoretical significance

Yolanda L.S. Smith, Stephanie H.M. van Goozen, A.J. Kuiper and Peggy T. Cohen-Kettenis

Psychiatry Research. Volume 137, Issue 3, 15 December 2005, Pages 151-160

 

Disorders of eating behavior: Correlation between hypothalamo-pituitary–thyroid function and psychopathological aspects

Francesca Brambilla, Paolo Santonastaso, Lorenza Caregaro and Angela Favaro

Psychoneuroendocrinology. Volume 31, Issue 1, January 2006, Pages 131-136

.

Regresar a RESÚMENES NOVIEMBRE 2005